
Bioporto A/S
CSE:BIOPOR

Bioporto A/S
Effect of Foreign Exchange Rates
Bioporto A/S
Effect of Foreign Exchange Rates Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Effect of Foreign Exchange Rates | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Bioporto A/S
CSE:BIOPOR
|
Effect of Foreign Exchange Rates
-kr636k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Genmab A/S
CSE:GMAB
|
Effect of Foreign Exchange Rates
kr1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
131%
|
CAGR 10-Years
41%
|
|
![]() |
Zealand Pharma A/S
CSE:ZEAL
|
Effect of Foreign Exchange Rates
kr6.2m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
10%
|
|
![]() |
Ascendis Pharma A/S
NASDAQ:ASND
|
Effect of Foreign Exchange Rates
€22.8m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
24%
|
CAGR 10-Years
30%
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Effect of Foreign Exchange Rates
-kr12.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Saniona AB
STO:SANION
|
Effect of Foreign Exchange Rates
kr9.8m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
Bioporto A/S
Glance View
Bioporto A/S engages in the provision of diagnostic tests and antibodies to healthcare professionals in clinical and research settings. The Company’s portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL Enzyme-linked immunosorbent assay (ELISA) kits, which supplies NGAL for the development of medicines for estimating side-effects that are harmful to kidneys; Mannan-binding Lectin (MBL) ELISA kit, which offers monoclonal MBL antibodies that are responsible for the activation of immune response; Antibodies, including monoclonal antibodies used in a range of research areas, such as microbiology, biomarkers, peptide hormones and plasma proteins; and Activated Protein C with Protein C Inhibitor Complex (APC-PCI), a biomarker applied to patients with sepsis and thrombotic and hemostatic disorders. In addition, the Company is a parent of BioPorto Diagnostics A/S.

See Also
What is Bioporto A/S's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
-636k
DKK
Based on the financial report for Sep 30, 2024, Bioporto A/S's Effect of Foreign Exchange Rates amounts to -636k DKK.